Potentiation of Neuroleptics by Catecholamine Inhibitors.

BMJ
doi 10.1136/bmj.1.5852.551-c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Alkaloid Derived From Evodia Fruit :Catecholamine Release Potentiation From the Cattle Adrenal by Evodiamine.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1994English

Potentiation of Anti-Cancer Agent Cytotoxicity by the Potent Poly(ADP-Ribose) Polymerase Inhibitors NU1025 and NU1064*

British Journal of Cancer
Cancer ResearchOncology
1998English

Neuroleptics and Psychic Indifference

Journal of the Royal Society of Medicine
Medicine
1990English

Potentiation of the Cytotoxicity of Thymidylate Synthase (TS) Inhibitors by Dipyridamole Analogues With Reduced Α1-Acid Glycoprotein Binding

British Journal of Cancer
Cancer ResearchOncology
1999English

AMPK Potentiation by LKB1 Isoforms

Oncotarget
Oncology
2015English

Application of Neuroleptics for Dementia

Japanese Journal of Geriatrics
GerontologyGeriatrics
2007English

Usage of Clozapine and New Neuroleptics

Psychiatric Bulletin
1999English

Neuroleptics and Bone Mineral Density

American Journal of Psychiatry
PsychiatryMental Health
1997English

Potentiation by ACE Inhibitors of the Dilator Response to Bradykinin in the Coronary Microcirculation: Interaction at the Receptor Level

British Journal of Pharmacology
Pharmacology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy